Who Paid My Doc
Michael Laposata
Clinical Pathology/Laboratory Medicine Galveston, TX Medical Doctor
NPI 1114999133 CMS profile 141280
301 University Blvd, Galveston, TX 77555
General payments
$45,819
Research payments
$0
Ownership & investment interest
$0
Through program year 2025, Michael Laposata of Galveston, TX is reported in the CMS Open Payments database as having received $45,819 across 26 general payments and $0 in research payments paid to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
General payments for this record sit in the 95th percentile of Clinical Pathology/Laboratory Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
7 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $43 | 1 | |
| 2024 | General | $25,298 | 8 | |
| 2023 | General | $4,830 | 6 | |
| 2022 | General | $1,700 | 1 | |
| 2021 | General | $1,700 | 1 | |
| 2020 | General | $7,500 | 3 | |
| 2019 | General | $4,748 | 6 |
Beside peers
- Michael Laposata
- Clinical Pathology/Laboratory Medicine median
- Middle half of Clinical Pathology/Laboratory Medicine
- National median
In program year 2025, general payments to Michael Laposata were reported at $43. Among 206 Clinical Pathology/Laboratory Medicine profiles paid that year, the median was $114 and the middle half received between $43 and $2,190.
Show as a table
| Year | Michael Laposata | Clinical Pathology/Laboratory Medicine median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $4,748 | $100 | $25–$525 | $163 |
| 2020 | $7,500 | $127 | $24–$3,383 | $114 |
| 2021 | $1,700 | $124 | $28–$2,259 | $132 |
| 2022 | $1,700 | $100 | $36–$1,512 | $149 |
| 2023 | $4,830 | $125 | $30–$797 | $160 |
| 2024 | $25,298 | $127 | $30–$1,800 | $164 |
| 2025 | $43 | $114 | $43–$2,190 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Billing to Medicare
Part B · data year 2024 · 8 billing codesPaid by Medicare
$1,968
Medicare patients
63
Services billed
67
| Condition among their Medicare patients | Relative to the most common | Share of patients |
|---|---|---|
| High blood pressure | 75% | |
| Cancer | 59% | |
| Arthritis | 44% | |
| Diabetes | 40% | |
| Heart failure | 37% | |
| Chronic kidney disease | 32% | |
| COPD | 29% | |
| Ischemic heart disease | 27% |
Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.
Records
26 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Clinical Pathology/Laboratory Medicine in Texas
Shelly Gunn
Clinical Pathology/Laboratory Medicine · San Antonio, TX
Richard Gomez
Clinical Pathology/Laboratory Medicine · Dallas, TX
Karen Roush
Clinical Pathology/Laboratory Medicine · Dallas, TX
Raul Benavides
Clinical Pathology/Laboratory Medicine · Dallas, TX
Dipen Maru
Clinical Pathology/Laboratory Medicine · Houston, TX
Martin Matzuk
Clinical Pathology/Laboratory Medicine · Houston, TX
Related records
Clinical Pathology/Laboratory Medicine in Texas
Practitioners in the same specialty and state, ranked by reported value.
All Clinical Pathology/Laboratory Medicine
Everyone recorded under this specialty, nationwide.
Doctors in Texas
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.